retatrutide clinical trials phase III study demonstrates 30% weight loss Retatrutide Meets Phase 3 Weight-Loss

Semaglutide, Tirzepatide, and Retatrutide all fall into this category, though each generation adds more receptor targets

Over the following average follow-up period of 11 months, incidence rates per 1,000 person-years were 21.4 for osteoarthritis, 21.1 for CKD, 20.3 for OSA, and 3.9 for heart failure

[PubMed: 4431434] 30

[13] On 2 May 2023, Jenny Craig announced to employees via email that the company will wind down operations, lay off all employees, and possibly switch to an e-commerce model

Berberine: This plant-based compound found in various herbs has shown potential in increasing GLP-1 levels and improving glucose metabolism

The timing of your GLP-1 around surgery is a medical decision, not a scheduling convenience